Showing 1 - 10 of 259,991
Persistent link: https://www.econbiz.de/10011488665
In this paper, we offer a novel explanation to the surge in patenting bserved during the last years. With low … patentability standards at PTOs (Patent and Trademark Offices awarding so-called bad patents), not only “false innovators” have the … chance of being granted patents but also, and more interestingly, “true innovators” are forced to patent more intensively …
Persistent link: https://www.econbiz.de/10013051385
In this paper, we offer a novel explanation to the surge in patenting bserved during the last years. With low … patentability standards at PTOs (Patent and Trademark Offices awarding so-called bad patents), not only "false innovators" have the … chance of being granted patents but also, and more interestingly, "true innovators" are forced to patent more intensively …
Persistent link: https://www.econbiz.de/10010398610
In this paper, we offer a novel explanation to the surge in patenting bserved during the last years. With low … patentability standards at PTOs (Patent and Trademark Offices awarding so-called bad patents), not only “false innovators” have the … chance of being granted patents but also, and more interestingly, “true innovators” are forced to patent more intensively …
Persistent link: https://www.econbiz.de/10010781546
We investigate how international patent activity enables firms from emerging economies to thrive in the global … marketplace. We match Chinese customs data to US patent records, and leverage the quasi-random assignment of USPTO patent … examiners to identify the causal effect of a US patent grant on the subsequent export performance of Chinese firms. Successful …
Persistent link: https://www.econbiz.de/10014434285
higher levels of innovation and lower levels of secrecy. An increase in the size of the market, a reduction in the cost of …
Persistent link: https://www.econbiz.de/10014072809
crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …
Persistent link: https://www.econbiz.de/10012802183
Novelty value is one of the legal requirements for a patentable innovation but it has been given relatively little … attention in the literature. It is often abstracted away by assuming that any innovation is patentable. We study the optimal … novelty requirement in a model where ideas are scarce, and where turning an idea into an innovation requires resources. We …
Persistent link: https://www.econbiz.de/10014219953
innovation. We study the equilibrium innovation activity under three regimes: patents, no-patents and patent pools. Patent pools … increase the probability of innovation with respect to patents, but we also find that: (1) their outcome can be replicated by a … licensing scheme in which innovators sell complete patent rights, and (2) they are dynamically unstable. We find that none of …
Persistent link: https://www.econbiz.de/10014046358
the signalling value of patents, and mitigating financial barriers to innovation. …How does patent examination influence access to finance for innovative firms? We exploit a reform to the UK's patent … system that introduced substantive examination to the patent application process, improving the information available to …
Persistent link: https://www.econbiz.de/10015189807